Slide background

Slide background
Slide background
Slide background

Loading Events
New York Cancer Genomics Research Network Meeting

5:00 PM — 8:00 PM

Moderated by Harold Varmus, MD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR


To advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (NYGC & Weill Cornell Medicine), Marcin Imielinski (NYGC &Weill Cornell Medicine), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University). 
Norman (Ned) Sharpless, the recently appointed Director of the National Cancer Institute (NCI), will conclude his visit to the NYGC by speaking at 5PM about his experiences at the NCI thus far and his future plans.
Since the cancer research community in New York City is heavily dependent on NCI policies, activities, and funding, this will be an important event. In addition, Dr. Sharpless will be followed by Professor Simon Tavaré, who has recently arrived in New York from Cambridge University to direct programs that include computational approaches to cancer genomics at Columbia University and the NYGC.
We urge you and colleagues at all career phases to attend this exciting and informative session.
Tuesday, November 6, 2018
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Hors d’oeuvres & Networking
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium


Harold Varmus, MD 
Senior Associate Core Member
New York Genome Center
Lewis Thomas University Professor of Medicine
Weill Cornell Medicine

Norman Sharpless, MD
National Cancer Institute
“Data Science and Cancer Care”
Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.
Dr. Sharpless was a Morehead Scholar at UNC–Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston.
After 2 years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.
Dr. Sharpless is a member of the Association of American Physicians as well as the American Society for Clinical Investigation (ASCI), the nation’s oldest honor society for physician–scientists, and served on the ASCI council from 2011 to 2014. Dr. Sharpless was an associate editor of Aging Cell and deputy editor of the Journal of Clinical Investigation. He has authored more than 150 original scientific papers, reviews, and book chapters, and is an inventor on 10 patents. He cofounded two clinical-stage biotechnology companies: G1 Therapeutics and HealthSpan Diagnostics.
In addition to serving as Director of NCI, Dr. Sharpless continues his research in understanding the biology of the aging process that promotes the conversion of normal self-renewing cells into dysfunctional cancer cells. Dr. Sharpless has made seminal contributions to the understanding of the relationship between aging and cancer, and in the preclinical development of novel therapeutics for melanoma, lung cancer, and breast cancer.
To learn more about Dr. Sharpless’ research, visit his profile page.

Simon Tavaré, PhD

Senior Associate Core Member
New York Genome Center
Director, Irving Institute for Cancer Dynamics
Departments of Statistics and Biological Sciences
Columbia University
“Computational Cancer Genomics at NYGC and Beyond”
Simon Tavaré, PhD, is a Senior Associate Core Member at the New York Genome Center (NYGC).  Dr. Tavaré, one of the world’s experts in statistics and probability in computational biology, became Founding Director of the Herbert and Florence Irving Institute of Cancer Dynamics at Columbia University in July 2018. He also holds appointments at Columbia in the departments of Statistics and Biological Sciences and as a member of the Herbert Irving Comprehensive Cancer Center.
Prior to joining Columbia, Dr. Tavaré was Director of the Cancer Research UK Cambridge Institute, and Professor in the Departments of Oncology and Applied Mathematics and Theoretical Physics at the University of Cambridge.
His research interests include statistical genetics, evolutionary approaches to cancer and stochastic computation. Dr. Tavaré forges connections and collaborations between the NYGC and other cancer research centers around the world, including leading a community-wide working group to build collaborations in cancer analytics.
He spent 25 years in academia in the United States before moving to Cambridge in 2004. He was elected as a Fellow of the Academy of Medical Sciences and in 2011 as a Fellow of the Royal Society. He currently serves as President of the London Mathematical Society. Dr. Tavaré received his BSc degree, MSc degree and PhD in Probability and Statistics from the University of Sheffield, UK.
To learn more about Dr. Tavaré’s research, visit his profile page.

Discussion and Q&A
Moderated by Harold Varmus, MD
Discussion and Q&A will take place after each speaker presents.
These meetings are held on the first Tuesday of each month and are intended for principal investigators in the New York region and their trainees.
Any questions on this event, contact



  • Workshops
  • Neurodegenerative Disease Working Group Evening Lectures
    The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including Alzheimer’s, Parkinson’s and Huntington’s diseases. The NYGC has created a new Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center, with the objective of bringing together researchers from NYGC’s institutional founding members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neurodegenerative disease.

  • Population Genomics Working Group Evening Lectures
    The NYGC has created a Population Genomics Working Group that brings together leading population and statistical geneticists and focuses on human population genomics, statistical analyses, and applications to precision medicine. The group is led by Eimear Kenny, PhD, of the Icahn School of Medicine at Mount Sinai, and Adam Siepel, PhD, of Cold Spring Harbor Laboratory.